BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 32764924)

  • 1. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery.
    Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD
    Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate-receptor-targeted laser-activable poly(lactide-
    Liu F; Chen Y; Li Y; Guo Y; Cao Y; Li P; Wang Z; Gong Y; Ran H
    Int J Nanomedicine; 2018; 13():5139-5158. PubMed ID: 30233177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
    Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization, Characterization and in vivo Evaluation of Paclitaxel-Loaded Folate-Conjugated Superparamagnetic Iron Oxide Nanoparticles.
    Gui G; Fan Z; Ning Y; Yuan C; Zhang B; Xu Q
    Int J Nanomedicine; 2021; 16():2283-2295. PubMed ID: 33776433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of folate- pegylated polyester nanoparticles encapsulating ixabepilone for targeting folate receptor overexpressing breast cancer cells.
    Siafaka P; Betsiou M; Tsolou A; Angelou E; Agianian B; Koffa M; Chaitidou S; Karavas E; Avgoustakis K; Bikiaris D
    J Mater Sci Mater Med; 2015 Dec; 26(12):275. PubMed ID: 26543021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery.
    Wang J; Liu W; Tu Q; Wang J; Song N; Zhang Y; Nie N; Wang J
    Biomacromolecules; 2011 Jan; 12(1):228-34. PubMed ID: 21158381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
    Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target-specific cellular uptake of taxol-loaded heparin-PEG-folate nanoparticles.
    Wang Y; Wang Y; Xiang J; Yao K
    Biomacromolecules; 2010 Dec; 11(12):3531-8. PubMed ID: 21086982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low density lipoprotein mimic nanoparticles composed of amphipathic hybrid peptides and lipids for tumor-targeted delivery of paclitaxel.
    Qian J; Xu N; Zhou X; Shi K; Du Q; Yin X; Zhao Z
    Int J Nanomedicine; 2019; 14():7431-7446. PubMed ID: 31686815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.
    Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y
    J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
    Su M; Xie J; Zeng Q; Shu M; Liu J; Jiang Z
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111125. PubMed ID: 32600724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-conjugated β-cyclodextrin from click chemistry strategy and for tumor-targeted drug delivery.
    Zhang H; Cai Z; Sun Y; Yu F; Chen Y; Sun B
    J Biomed Mater Res A; 2012 Sep; 100(9):2441-9. PubMed ID: 22566147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifunctional pH-Responsive Folate Receptor Mediated Polymer Nanoparticles for Drug Delivery.
    Cai X; Yang X; Wang F; Zhang C; Sun D; Zhai G
    J Biomed Nanotechnol; 2016 Jul; 12(7):1453-62. PubMed ID: 29337470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity.
    Zhang C; Zhang Z; Zhao L
    Drug Deliv; 2016 Jun; 23(5):1830-7. PubMed ID: 26652055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facile synthesis of polyester-PEG triblock copolymers and preparation of amphiphilic nanoparticles as drug carriers.
    Vassiliou AA; Papadimitriou SA; Bikiaris DN; Mattheolabakis G; Avgoustakis K
    J Control Release; 2010 Dec; 148(3):388-95. PubMed ID: 20869413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Folic Acid Receptor-Targeted Drug Delivery System Based on Curcumin-Loaded β-Cyclodextrin Nanoparticles for Cancer Treatment.
    Hong W; Guo F; Yu N; Ying S; Lou B; Wu J; Gao Y; Ji X; Wang H; Li A; Wang G; Yang G
    Drug Des Devel Ther; 2021; 15():2843-2855. PubMed ID: 34234415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shedding light on surface exposition of poly(ethylene glycol) and folate targeting units on nanoparticles of poly(ε-caprolactone) diblock copolymers: Beyond a paradigm.
    Venuta A; Moret F; Dal Poggetto G; Esposito D; Fraix A; Avitabile C; Ungaro F; Malinconico M; Sortino S; Romanelli A; Laurienzo P; Reddi E; Quaglia F
    Eur J Pharm Sci; 2018 Jan; 111():177-185. PubMed ID: 28966100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.